NetworkNewsBreaks

TuesdayJun 06, 2017 12:44 pm

NetworkNewsBreaks – CTI BioPharma Corp. (NASDAQ: CTIC) Prices $45M Offering of Convertible Preferred Stock; Shares Down, but Lift from New 52-Week Low

CTI BioPharma Corp. ("CTI") (NASDAQ: CTIC) this morning priced its underwritten public offering of 22,500 shares of its Series N-3 Preferred Stock at $2,000 per share. The company said it expects gross proceeds from the offering of $45 million. Net proceeds will be used to conduct the PAC203 clinical trial; submit a new Marketing Authorization Application for pacritinib to the European Medicines Agency; conduct additional research concerning the possible application of pacritinib in indications outside of myelofibrosis; and complete the PIX306 clinical trial, as well as for general corporate purposes, which may include funding research and development, conducting preclinical and clinical…

Continue Reading

TuesdayJun 06, 2017 11:32 am

NetworkNewsBreaks – NII Holdings, Inc.’s (NASDAQ: NIHD) AINMT Partnership Sends Shares Soaring on Heavy Volume

Shares of NII Holdings (NASDAQ: NIHD) are up more than 40% mid-day on volume of 12.21 million, roughly three times the average 5-day volume, on word the mobile communication services provider has partnered with AINMT Holdings AB ("AINMT"), an international telecommunications company and parent of the Norwegian operator ice, to jointly own and operate Brazilian mobile telecommunications company Nextel Brazil. Per the agreement, AINMT will invest $50 million for a 30% stake in Nextel Holdings S.à r.l. (the "Company"), a wholly owned subsidiary of NII and owner of Nextel Brazil. AINMT has the option to invest an additional $150 million…

Continue Reading

TuesdayJun 06, 2017 9:27 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Teams with First Bitcoin Capital (BITCF) to Develop Bitcoin Payments Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced an initiative to develop a bitcoin payments solution in partnership with First Bitcoin Capital Corp. (OTC: BITCF), an industry-leading bitcoin and blockchain technology provider. Per the news release, the two companies have signed a joint venture agreement to develop and distribute a viable payments solution targeted at “high-risk payment verticals including the cannabis industry” in order to “fill the payments gap that currently exists.” Through this new partnership, SinglePoint and First Bitcoin Capital intend to focus on their respective core strengths in order to build and supply the best bitcoin…

Continue Reading

TuesdayJun 06, 2017 8:58 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Engagement of Venture Building Firm Launch Haus, LLC

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its engagement of Launch Haus, LLC, a venture building firm and digital holding company specializing in direct response marketing. Moving forward, Launch Haus is expected to play an “integral part” in directing CIIX’s corporate organization, as well as its planned launch of direct-to-consumer ecommerce and network marketing business divisions. “Launch Haus is the perfect firm to oversee CIIX's direct response marketing campaign which will include significant direct-to-consumer ecommerce channels such as Amazon and development of the Company's international network marketing platform as we begin to drive revenues in the coming…

Continue Reading

MondayJun 05, 2017 12:49 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on June 5, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CLSN 60.90% – News: Presents “promising” OVATION study results SPCB 8.26% – News: Posts 42% increase in Q1 sales, improves gross margin by 150% PTIE 6.60% – News: Awarded $1.7 million grant by the National Institutes of Health for Alzheimer’s candidate ATOM 6.05% – News: Presenting at LD Micro Conference on June 6, Marcum Microcap on June 15 FORK 4.69% – News: Opens new manufacturing facility in China with capacity to expand annual production…

Continue Reading

MondayJun 05, 2017 12:47 pm

NetworkNewsBreaks – Pain Therapeutics, Inc. (NASDAQ: PTIE): $1.7M Grant from NIH Supports Study of Alzheimer’s Candidate

Pain Therapeutics (NASDAQ: PTIE) is trading higher on word the biopharmaceutical company has received from the National Institutes of Health (NIH) a $1.7 million research grant to study PTI-125, a drug candidate, in Alzheimer’s disease. With this grant, Pain Therapeutics can begin testing PTI-125 in human subjects. The company said it is on track to file an Investigational New Drug (IND) application in the third quarter of 2017. "We are once again grateful to the NIH for its support of our research program around PTI-125," Pain Therapeutics chairman, president and CEO Remi Barbier stated in the news release. "NIH has…

Continue Reading

MondayJun 05, 2017 12:21 pm

NetworkNewsBreaks – Celsion Corp. (NASDAQ: CLSN) Presents “Encouraging” OVATION Study Results; Shares Surge on Heavy Volume

Shares of Celsion (NASDAQ: CLSN) are up 57.8% on volume of 15.98 million in mid-day trade after the oncology drug development company issued an update on its OVATION study, a phase Ib dose escalating clinical trial assessing the combination of GEN-1, Celsion’s DNA-based immunotherapy, with the standard of care for the treatment of newly diagnosed patients with advanced ovarian cancer who will undergo neoadjuvant chemotherapy followed by interval debulking surgery. “The OVATION study has accrued patients from four major research cancer centers.  We have seen highly promising clinical findings including a patient with a complete pathological response along with a very high…

Continue Reading

MondayJun 05, 2017 12:12 pm

NetworkNewsBreaks – AntriaBio (ANTB) Files IND Application for Diabetes Candidate, Plans for Phase 1 First-in-Human Clinical Trial; Shares Lower

Shares of AntriaBio (OTCQB: ANTB) are 10% lower in morning trade after the biopharmaceutical company said it has filed an Investigational New Drug (IND) application with the FDA for AB101, the company’s once-weekly basal insulin for patients with diabetes mellitus. AntriaBio said it intends to subsequently initiate a phase 1 first-in-human clinical study to assess the safety and tolerability, pharmacokinetics and time-action profile of single ascending doses of AB101, administered to subjects with Type 1 diabetes mellitus. To view the full press release, visit: http://nnw.fm/1oHbk About AntriaBio, Inc. AntriaBio is a patient-centric biopharmaceutical growth company specializing in the development of…

Continue Reading

MondayJun 05, 2017 10:58 am

NetworkNewsBreaks – ImageWare Systems, Inc. (IWSY) Expands Market Reach in North America with Info X Distribution Agreement

ImageWare Systems (OTCQB: IWSY), a provider of mobile and cloud-based, multi-modal biometric identity management solutions, this morning said it has entered into an agreement in which Info X Distribution will market and resell ImageWare’s GoVerifyID Enterprise Suite and SaaS solutions. "Our partnership with Info X Distribution broadens our reach to thousands of additional resellers as Info X will actively market our GoVerifyID suite of products throughout North America. We look forward to providing multi-modal biometrics to their diverse network of existing and prospective customers," ImageWare chairman and CEO Jim Miller stated in the news release. To view the full press…

Continue Reading

FridayJun 02, 2017 12:29 pm

NetworkNewsBreak – Top 10 Mid-day Percentage Gainers on June 2, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: SVON 19.23% – News: Signs definitive agreement for an acquisition transaction with Eloxx CTHR 8.43% – News: Collaborates with American Gem Society to raise Moissanite awareness YIPI 7.18% – News: Elects new member to board of directors AMMA 5.00% – News: Schedules inaugural event for August 19th at the Tampa Convention Center NK 4.92% – News:  Presenting at the Jefferies 2017 Global Healthcare Conference in New York City on June 7 HPJ 4.17% –…

Continue Reading